RARE Market Cap History Table | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Also see: RARE Shares Outstanding History and RARE YTD Return |
RARE Market Cap History Table | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Also see: RARE Shares Outstanding History and RARE YTD Return |
RARE Market Cap History Chart | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
+13.65% CAGR ![]() Mouse over chart for data details
|
RARE Stock Price Chart |
About Ultragenyx Pharmaceutical Inc |
Ultragenyx Pharmaceutical Inc. is a biopharmaceutical company focused on developing and commercializing treatments for rare and ultrarare genetic diseases. Their therapies and pipeline include biologics, small molecules, AAV gene therapy, and nucleic acid product candidates. Approved products are Crysvita for X-linked hypophosphatemia (XLH) and tumor-induced osteomalacia (TIO), Mepsevii for mucopolysaccharidosis VII (MPSVII), Dojolvi for long-chain fatty acid oxidation disorders (LC-FAOD), and Evkeeza for homozygous familial hypercholesterolemia (HoFH). Clinical candidates include DTX401 for glycogen storage disease type Ia, DTX301, and UX701. We show 46 historical shares outstanding datapoints in our RARE shares outstanding history coverage, used to compute RARE market cap on those dates. Understanding the changing numbers of shares outstanding, the changing share price, and the resulting changing RARE market cap history over the course of time is important for investors interested in comparing RARE's market cap history versus its peers. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies, and then calculating their respective market caps. Comparing the share price of RARE versus a peer is one thing; comparing RARE market cap versus a peer is a completely different story. Furthermore, via fluctuation both in per-share price and in the number of shares outstanding (via issuance of new shares over time, the repurchase of existing shares), the market cap for a company like RARE can fluctuate over the course of history. With this page we aim to empower investors researching RARE by allowing them to research the RARE market cap history. |
RARE Current Stock Quote |
![]() Get Dividend Alerts ![]() Get SEC Filing Alerts ![]() |
Video: The Importance of Market Cap | |
|
RARE Share Performance |
Market Cap Peers |
Ultragenyx Pharmaceutical (RARE) is categorized under the Healthcare sector; to help you further research historical market cap numbers, below are some other companies in the same sector:
RARX Market Cap History |
Click the button below for your complimentary copy of Your Early Retirement Portfolio: Dividends Up to 8.3%—Every Month—Forever.
You'll discover the details on 4 stocks and funds that pay you massive dividends as high as 8.3%.